-
Results from a Phase 3 study of dabigatran, intensive lipid-lowering in CVD, H1N1 vaccine dosing and efficacy, and FDA Actions
-
The early ECGs are the mainstay of predicting the culprit coronary artery in ST-segment elevation myocardial infarction (STEMI)
-
Recent controversy has erupted concerning the use of prophylactic beta-blockers in patients with known or suspected coronary artery disease (CAD) undergoing non-cardiac surgery.
-
Current guidelines recommend monotherapy with either beta-blockers or rate lowering calcium blockers for heart rate control in patients with permanent atrial fibrillation (AF).
-
This was a retrospective cohort study from Quebec and Ontario, Canada, examining patients ≥ 65 years of age admitted to a hospital with a diagnosis of atrial fibrillation (AF) between 1998 and 2007.
-
Beta-blockers have long been considered a cornerstone of therapy for patients with acute myocardial infarction (MI).
-
Resistant hypertension, defined as a systolic blood pressure (BP) that remains above goal despite treatment with at least three complementary antihypertensive agents of different classes at maximally tolerated doses, has become an increasingly common diagnosis in recent years.
-
Coronary artery stents are implanted in the vast majority of coronary revascularization procedures, owing to improvements in both restenosis and acute vessel occlusion vs balloon angioplasty alone.
-
The cause of ischemic stroke remains uncertain despite a complete diagnostic evaluation in many cases. Detection of atrial fibrillation (AF) after cryptogenic stroke would have important therapeutic implications.
-
The clinical implications of the recovery of left ventricular (LV) function after treatment of patients with initial systolic heart failure is poorly understood.
